HEATHER TALBOTT: Open Payments
NPI 1144745761 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$131 in 8 payments from 7 companies in 2025. Trend: 2023 $82 · 2024 $23 · 2025 $131
Food & beverage: $131
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $29 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Medtronic, Inc. | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| CooperSurgical, Inc. | 1 | $15 |
| ABBVIE INC. | 1 | $14 |
Products named: KEVEYIS, KYPHON EXPRESS II KYPHOPAK TRAY, NEXLETOL, REXULTI, Paragard T 380A, KISUNLA, VRAYLAR.
Industry payments across NE — which companies pay providers there.
